Johnson & Johnson and AstraZeneca are studying whether modifying their COVID-19 vaccines can reduce or eliminate the risk of rare blood clots

[sriamerican]

• Johnson & Johnson and AstraZeneca-University of Oxford have begun studying whether their COVID-19 vaccines can be modified
• Both shots have been linked to a risk of blood clots along with a low platelet-count condition known as thrombocytopenia
• Scientists hope to identify the causes behind the blood clots and maybe re-engineer the shots by next year
• In the U.S., J&J's vaccine has been linked to 0.3 cases of rare blood clots per 100,000 doses and AstraZeneca's jab linked to 1-2 cases per 100,000
• It comes one day after it was revealed the FDA is adding a new warning to the label of J&J's vaccine due the risk of a rare autoimmune disorder

 

[imhotep]

The last I heard on this was that J&J was going to consult Dr Rolf Marschalek who found the possible reason for clotting, on the vaccine changes.
Pls refer to my old post on this...
https://elakiri.com/threads/german-...ed-the-vaccine-blood-clotting-puzzle.1990891/

 

[Stimulus mind]

 

[hodakolla]

BUMPER